214 related articles for article (PubMed ID: 17255139)
1. TPMT testing in rheumatology: any better than routine monitoring?
Payne K; Newman W; Fargher E; Tricker K; Bruce IN; Ollier WE
Rheumatology (Oxford); 2007 May; 46(5):727-9. PubMed ID: 17255139
[No Abstract] [Full Text] [Related]
2. Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprine.
Seidman EG; Furst DE
J Rheumatol; 2002 Dec; 29(12):2484-7. PubMed ID: 12465139
[No Abstract] [Full Text] [Related]
3. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients on azathioprine: a need for a better pre-treatment assessment and dosing guideline.
Jabin D; Kumar S; Gow PJ
N Z Med J; 2010 Oct; 123(1324):67-73. PubMed ID: 20953224
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of an intravenous loading dose of azathioprine for treatment of non-TPMT-deficient patients with rheumatic diseases.
Pickenpack A; Straub RH; Distler O; Hammond A; Oellerich M; Schölmerich J; Lang B; Schütz E
Rheumatology (Oxford); 2000 Dec; 39(12):1435-6. PubMed ID: 11136898
[No Abstract] [Full Text] [Related]
6. Thiopurine methyltransferase genotype and the toxicity of azathioprine in Japanese.
Ishioka S; Hiyama K; Sato H; Yamanishi Y; McLeod HL; Kumagai K; Maeda H; Yamakido M
Intern Med; 1999 Dec; 38(12):944-7. PubMed ID: 10628931
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoeconomic analysis of thiopurine methyltransferase polymorphism screening by polymerase chain reaction for treatment with azathioprine in Korea.
Oh KT; Anis AH; Bae SC
Rheumatology (Oxford); 2004 Feb; 43(2):156-63. PubMed ID: 12923290
[TBL] [Abstract][Full Text] [Related]
8. TPMT testing before azathioprine therapy?
Drug Ther Bull; 2009 Jan; 47(1):9-12. PubMed ID: 19129430
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphism to disclose severe side-effects or proper dosage for each patient.
Ichikawa Y
Intern Med; 2000 Jul; 39(7):523-4. PubMed ID: 10888203
[No Abstract] [Full Text] [Related]
10. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
11. [Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].
Zhan ZP; Liang LQ; Yang XY; Wang YX; Huang M; Li H
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1734-7. PubMed ID: 17919375
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for prescribing azathioprine in dermatology.
Anstey AV; Wakelin S; Reynolds NJ;
Br J Dermatol; 2004 Dec; 151(6):1123-32. PubMed ID: 15606506
[TBL] [Abstract][Full Text] [Related]
13. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
Firooz A; Ghandi N; Hallaji Z; Chams-Davatchi C; Valikhani M; Karbakhsh Davari M
Arch Dermatol; 2008 Sep; 144(9):1143-7. PubMed ID: 18794458
[TBL] [Abstract][Full Text] [Related]
14. Azathioprine: when less is more.
Duley JA; Florin TH
J Gastroenterol Hepatol; 2008 Sep; 23(9):1317-9. PubMed ID: 18853992
[No Abstract] [Full Text] [Related]
15. The possible clinical application of pharmacogenetics in rheumatology.
Ferraccioli G
J Rheumatol; 2003 Dec; 30(12):2517-20. PubMed ID: 14719186
[No Abstract] [Full Text] [Related]
16. Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome.
Shah JA; Edwards CM; Probert CS
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):169-73. PubMed ID: 18301295
[TBL] [Abstract][Full Text] [Related]
17. [Biologics].
Kalden JR
Z Rheumatol; 2016 Aug; 75(6):604-10. PubMed ID: 27365024
[No Abstract] [Full Text] [Related]
18. [Tapering and termination of immunosuppressive therapy].
Villiger PM; Müller-Ladner U
Z Rheumatol; 2017 Feb; 76(1):6-7. PubMed ID: 28097392
[No Abstract] [Full Text] [Related]
19. Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease.
Stocco G; Martelossi S; Decorti G; Bartoli F; Ventura A
Aliment Pharmacol Ther; 2007 Oct; 26(7):1083-4; author reply 1084-5. PubMed ID: 17877516
[No Abstract] [Full Text] [Related]
20. Resolution of a soft-tissue sarcoma in a patient with rheumatoid arthritis after discontinuation of azathioprine therapy.
Csuka ME; Hanson GA
Arch Intern Med; 1996 Jul; 156(14):1573-6. PubMed ID: 8687266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
